Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M (Q28594461)

Journal of Biological Chemistry

GOA release 2020-03-11

1 reference

1

Christian Wolfrum

1 reference

31 January 2017

Jessica J. Howell

2

1 reference

31 January 2017

Esther Ndungo

series ordinal

3

1 reference

31 January 2017

Markus Stoffel

series ordinal

4

1 reference

31 January 2017

language of work or name

English

0 references

publication date

13 June 2008

1 reference

31 January 2017

1 reference

31 January 2017

283

1 reference

31 January 2017

24

1 reference

31 January 2017

16940–16949

1 reference

31 January 2017

A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Genetic determinants of low high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

High-density lipoproteins: multifunctional vanguards of the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Proteomic analysis of high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Pre-beta HDL: structure and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

The metabolic syndrome: one step forward, two steps back

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

The metabolic syndrome: a global public health problem and a new definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Insulin resistance and type 2 diabetes--an adipocentric view

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Insulin resistance and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Insulin: new roles for an ancient hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Characterization of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-alpha and LP-beta, of importance for the differentiation-linked induction of the LPL gene during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Role of the liver in the control of carbohydrate and lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Sequential expression of HNF-3 beta and HNF-3 alpha by embryonic organizing centers: the dorsal lip/node, notochord and floor plate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Abnormal regulation of the leptin gene in the pathogenesis of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

High-density lipoprotein as a key component in the prevention of premature atherosclerotic disease in the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Hypertriglyceridemia is associated with prebeta-HDL concentrations in subjects with familial low HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Isolation and characterization of human apolipoprotein M-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M801930200